Amicus, Thermo Fisher "s Brammer Bio enter gene therapy collaboration
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Wall Street Journal: Thermo Fisher to acquire Brammer Bio in $1.7 billion gene-therapy deal
Thermo Fisher Scientific Inc. said it is buying Brammer Bio for $1.7 billion in a move that would expand the lab-equipment company’s presence in the rapidly growing field of gene therapy......»»
Thermo Fisher Makes Move In Gene Therapy Space To Help Services Business Unit
Thermo Fisher Makes Move In Gene Therapy Space To Help Services Business Unit.....»»
In major cell therapy manufacturing deal, UCSF, biotech tools leader Thermo Fisher go small to go big
The new cell therapy manufacturing facility, which will open early next year, will be able to deliver highly specialized cell therapies to patients in clinical trials at UCSF's women's, children's and cancer hospitals complex across Mariposa Street......»»
Thermo Fisher and UC San Francisco to open cell therapy manufacturing center
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Thermo Fisher sees $1B in Covid-19 vaccine and therapy revenue in 2021
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Thermo Fisher to buy Brammer Bio for $1.7B
Closely held Brammer Bio, owned by private-equity firm Ampersand Capital Partners......»»
Thermo Fisher to acquire Brammer Bio for $1.7B in cash
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Five things: South Station fire; Thermo Fisher, Vertex CEO pay; and a baseball team worth watching
Good morning, Boston. Happy National Siblings Day. Here are the five things you need to know in Boston business news to start your workday. The construction firm Suffolk has paused work on South Station Tower following a fire at the site yeste.....»»
Scientists partially restored a blind man"s vision using gene therapy and goggles
The first successful trial of a new .....»»
Biogen, Gingko Bioworks enter gene therapy collaboration, license agreement
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Passage Bio co-founders launch new company with $200M to fund gene therapies coming out of Penn
The company's founders are the director of Penn's gene therapy program and the former head of research and development at GlaxoSmithKline......»»
Biogen"s Retinal Disease Gene Therapy Flunks Mid-Stage Study
Biogen Inc (NASDAQ: BIIB) has announced topline results from the Phase 2/3 XIRIUS study evaluating cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients w.....»»
Otonomy, AGTC present preclinical results for OTO-825 gene therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen"s Retinal Disease Gene Therapy Flunks Mid-Stage Study
read more.....»»
uniQure presents clinical data from phase III HOPE-B gene therapy trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»